Close Menu
Home › Resources › Genomics: Clinical Implementation

Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests. 

Illumina-Sponsored Study Finds Liquid Biopsy Complements Tissue-Based Genotyping in Lung Cancer

The study adds to growing evidence around the utility of cell-free DNA testing in lung cancer patients, while highlighting shortcomings of the approach.

Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine

Premium

Experts discussed the benefits and challenges of implementing precision medicine protocols for oncology patients at this week's Tri-Conference meeting

First Veterans Affairs MDx Lab Launches NGS-Based Cancer Panel; Others to Follow

Premium

The VA decided to bring this testing in house to streamline and standardize the process for doctors and gauge markers that are relevant to the veteran population.

MD Anderson Study Adds Utility Evidence for Guardant Health Liquid Biopsy Test

Premium

Data being presented at the upcoming AACR meeting show that Guardant's liquid biopsy test provided more accurate and rapid mutation detection than tissue genotyping.

Weill Cornell, NYGC Group to Commercialize WGS Circulating Tumor DNA Cancer Recurrence Assay

Premium

The assay monitors mutations across a patient's genome and matches them to mutations found in a patient's resected tumor and in DNA in the bloodstream.

Feb 26, 2019

Health Organizations Collaborate to Launch Medical Genome Initiative

Feb 26, 2019

Thermo Fisher Scientific Oncomine Dx Target Test Gets Expanded Regulatory Approval in Japan

Feb 15, 2019

All Breast Cancer Patients Should Receive Multigene Panel Tests, Surgeon Group Says

Feb 12, 2019

SickKids Team Awarded $2.3M to Develop RNA Sequencing Dx for Rare Disease, Cancer

Premium
Feb 07, 2019

Agiomix to Validate Biocept Target Selector Liquid Biopsy Kits

Feb 05, 2019

Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department

Feb 04, 2019

Clinical Utility of Polygenic Risk Scores Questioned in Commentary

Premium
Feb 01, 2019

Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests

Feb 01, 2019

Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making

Premium
Jan 31, 2019

NGS-Based Lung Cancer Profiling Used Routinely by Heidelberg Research Team

Premium
Jan 30, 2019

OncoCyte Readies Lung Cancer Test for Launch, Previews New Platform Validation Data

Premium
Jan 24, 2019

Liquid Biopsy Dx Looks for Donor-Derived DNA as Measure of Chronic Lung Transplant Rejection

Premium
Jan 24, 2019

At PMWC, Experts Discuss Benefits, Challenges of Implementing Genomics in Health Systems

Premium
Jan 22, 2019

Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk

Premium
Jan 16, 2019

Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

Premium
Jan 15, 2019

Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ

Premium
Jan 11, 2019

Color Partnering With Health Systems Exploring Impact of Genomic Testing on Outcomes, Cost

Premium
Jan 09, 2019

Routine Genetic Testing to Be Implemented in New NorthShore-Color Partnership

Jan 09, 2019

Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs

Premium
Dec 26, 2018

Personalized Medicine 2018: More Drugs, Greater NGS Adoption, Growing Appreciation of Dx Value

Premium
More articles

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.